Lument Finance Trust (NYSE:LFT) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Speaker7Good morning, and thank you for joining the Lument Finance Trust fourth quarter 2025 earnings call. Today's call is being recorded and will be made available via webcast on the company's website. I would now like to turn the call over to Andrew Tsang with Investor Relations at Lument Investment Management. Please go ahead.Speaker0Morning, everyone, and thank you for joining our call to discuss Lument Finance Trust fourt ...

Concentrix (NasdaqGS:CNXC) Q1 2026 Earnings call March 24, 2026 08:30 AM ET Speaker0Hello, everyone. Thank you for joining us, and welcome to the Concentrix First Quarter 2026 Financial Results Conference Call. After today's prepared remarks, we will host a question and answer session. If you'd like to ask a question, please press star one on your telephone keypad. To withdraw your question, please press star one again. I will now hand the call over to Elise Purcell, Corporate Communications. Please go ahea ...

WuXi XDC Cayman (SEHK:02268) H2 2025 Earnings call March 24, 2026 08:30 AM ET Speaker0Good evening everyone, investors and analysts, and welcome to WuXi XDC 2025 full-year earnings conference call. This is Chris Fang, head of company IR, and I will be the facilitator for today's call. Our earnings presentation material has been uploaded to the company website earlier today, and you are welcome to download and review them. Let me introduce our management team joining us today. Our Company's CEO, Dr. Jimmy Li ...

Core & Main (NYSE:CNM) Q4 2026 Earnings call March 24, 2026 08:30 AM ET Speaker8Hello, and welcome to the Core & Main Q4 and full year 2025 earnings call. My name is Alex. I'll be coordinating today's call. If you'd like to ask a question at the end of the presentation, you may press star followed by one on your telephone keypad. I'll now hand it over to Glenn Floyd, Director of Investor Relations, to begin. Please go ahead.Speaker2Good morning, and thank you for joining us. I'm Glenn Floyd, Director of Inv ...

Fennec Pharmaceuticals (NasdaqCM:FENC) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Speaker3Good morning, ladies and gentlemen. Welcome to Fennec Pharmaceuticals' fourth quarter and full year 2025 earnings and corporate update conference call. At this time, all participants are on a listen-only mode. Later, we will conduct a question-and-answer session, and instructions on how to participate will be given at that time. As a reminder, today's conference call is being recorded. Now I'd like to send the co ...

Vertical Aerospace (NYSE:EVTL) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Speaker7Thank you for standing by. My name is Carly, and I will be your conference operator today. At this time, I would like to welcome everyone to the Vertical Aerospace Full Year 2025 Business and Strategy Update Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press s ...

Achieve Life Sciences (NasdaqCM:ACHV) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Speaker8Greetings, and welcome to the Achieve Life Sciences fourth quarter and full year 2025 earnings conference call and webcast. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. You will be placed into question queue at any time by pressing star one on your telephone keypad. As a reminder, this conference is being recorded. If anyone should requi ...

LENZ Therapeutics (NasdaqGS:LENZ) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Speaker1Good morning, and thank you for joining us today. My name is Dan Chevallard, Chief Financial Officer of LENZ Therapeutics. We are joined today by Evert Schimmelpennink, our President and Chief Executive Officer, and Shawn Olsson, our Chief Commercial Officer, as well as Dr. Marc Odrich, Chief Medical Officer, who will join us for the question-and-answer session. Before we begin, I would like to remind you that this ca ...

Ocugen (NasdaqCM:OCGN) Update / briefing March 24, 2026 08:00 AM ET Company ParticipantsAngela Qian - VP of Global Capital MarketsArun Upadhyay - Chief Scientific OfficerElemer Piros - Managing Director of Healthcare Equity ResearchHuma Qamar - Chief Medical OfficerJay Chhablani - ProfessorLejla Vajzovic - Professor of Ophthalmology and CME Program DirectorShankar Musunuri - Chairman, CEO, and Co-founderSyed Shah - Vice Chair for Research and Digital MedicineTiffany Hamilton - Head of Corporate Communicatio ...

Sanara MedTech (NasdaqCM:SMTI) Q4 2025 Earnings call March 24, 2026 08:00 AM ET Company ParticipantsElizabeth Taylor - CFOSeth Yon - President and CEOConference Call ParticipantsEduardo Rafael Martinez-Montes - Biotech Equity Research AnalystOperatorWelcome to the Sanara MedTech fourth quarter and full year 2025 earnings conference call. Please note that this conference call is being recorded and a replay will be available on the investor relations page of the company's website shortly. The company issued i ...